Related Experiment Video
Updated: Nov 28, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication
Soren Alexandersen1,2,3, Anthony Chamings4,5, Tarka Raj Bhatta4,5
1Geelong Centre for Emerging Infectious Diseases, Geelong, VIC, 3220, Australia. soren.alexandersen@deakin.edu.au.
Abstract:
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first detected in late December 2019 and has spread worldwide. Coronaviruses are enveloped, positive sense, single-stranded RNA viruses and employ a complicated pattern of virus genome length RNA replication as well as transcription of genome length and leader containing subgenomic RNAs. Although not fully understood, both replication and transcription are thought to take place in so-called double-membrane vesicles in the cytoplasm of infected cells. Here we show detection of SARS-CoV-2 subgenomic RNAs in diagnostic samples up to 17 days after initial detection of infection and provide evidence for their nuclease resistance and protection by cellular membranes suggesting that detection of subgenomic RNAs in such samples may not be a suitable indicator of active coronavirus replication/infection.
More Related Videos
07:54Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
11:11Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viruses with RNA Genomes